PDF Publication Title:
Text from PDF Page: 013
Healthcare 2020, 8, 10 13 of 14 12. Mao, J.J.; Palmer, C.S.; Healy, K.E.; Desai, K.; Amsterdam, J. Complementary and alternative medicine use among cancer survivors: A population-based study. J. Cancer Surviv. 2011, 5, 8–17. [CrossRef] 13. Golden, R.N.; Gaynes, B.N.; Ekstrom, R.D.; Hamer, R.M.; Jacobsen, F.M.; Suppes, T.; Wisner, K.L.; Nemeroff, C.B. The efficacy of light therapy in the treatment of mood disorders: A review and meta-analysis of the evidence. Am. J. Psychiatry 2005, 162, 656–662. [CrossRef] 14. Johnson, J.A.; Garland, S.N.; Carlson, L.E.; Savard, J.; Simpson, J.S.A.; Ancoli-Israel, S.; Campbell, T.S. Bright light therapy improves cancer-related fatigue in cancer survivors: A randomized controlled trial. J. Cancer Surviv. 2018, 12, 206–215. [CrossRef] 15. Valdimarsdottir, H.B.; Figueiro, M.G.; Holden, W.; Lutgendorf, S.; Wu, L.M.; Ancoli-Israel, S.; Chen, J.; Hoffman-Peterson, A.; Granski, J.; Prescott, N.; et al. Programmed environmental illumination during autologous stem cell transplantation hospitalization for the treatment of multiple myeloma reduces severity of depression: A preliminary randomized controlled trial. Cancer Med. 2018, 7, 4345–4353. [CrossRef] 16. Redd, W.H.; Valdimarsdottir, H.; Wu, L.; Winkel, G.; Byrne, E.E.; Beltre, M.A.; Liebman, E.S.; Erazo, T.; Hayes, J.A.; Isola, L.; et al. Systematic light exposure in the treatment of cancer-related fatigue: A preliminary study. Psychooncology 2014, 23, 1431–1434. [CrossRef] 17. Kronish, I.M.; Alcántara, C.; Duer-Hefele, J.; Onge, T.S.; Davidson, K.W.; Carter, E.J.; Medina, V.; Cohn, E.; Moise, N. Patients and primary care providers identify opportunities for personalized (N-of-1) trials in the mobile health era. J. Clin. Epidemiol. 2017, 89, 236–237. [CrossRef] [PubMed] 18. Duan, N.; Kravitz, R.L.; Schmid, C.H. Single-patient (n-of-1) trials: A pragmatic clinical decision methodology for patient-centered comparative effectiveness research. J. Clin. Epidemiol. 2013, 66, S21–S28. [CrossRef] [PubMed] 19. Duan, N.; Eslick, I.; Gabler, N.B.; Kaplan, H.C.; Kravitz, R.L.; Larson, E.B.; Pace, W.D.; Schmid, C.H.; Sim, I.; Vohra, S. Design and Implementation of N-of-1 Trials: A User’s Guide; Kravitz, R., Duan, N., Eds.; Agency for Healthcare Research and Quality: Rockville, MD, USA, 2014. 20. Guyatt, G.H.; Haynes, R.B.; Jaeschke, R.Z.; Cook, D.J.; Green, L.; Naylor, C.D.; Wilson, M.C.; Richardson, W.S.; Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature: XXV. Evidence-based medicine: Principles for applying the Users’ Guides to patient care. JAMA 2000, 284, 1290–1296. [CrossRef] [PubMed] 21. Lillie, E.O.; Patay, B.; Diamant, J.; Issell, B.; Topol, E.J.; Schork, N.J. The n-of-1 clinical trial: The ultimate strategy for individualizing medicine? Pers. Med. 2011, 8, 161–173. [CrossRef] 22. Johnston, B.C.; Mills, E. N-of-1 randomized controlled trials: An opportunity for complementary and alternative medicine evaluation. J. Altern. Complement. Med. 2004, 10, 979–984. [CrossRef] 23. Vohra, S.; Shamseer, L.; Sampson, M.; Bukutu, C.; Schmid, C.H.; Tate, R.; Nikles, J.; Zucker, D.R.; Kravitz, R.; Guyatt, G.; et al. CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. J. Clin. Epidemiol. 2016, 76, 9–17. [CrossRef] 24. Kroenke, K.; Strine, T.W.; Spitzer, R.L.; Williams, J.B.; Berry, J.T.; Mokdad, A.H. The PHQ-8 as a measure of current depression in the general population. J. Affect. Disord. 2009, 114, 163–173. [CrossRef] 25. Rea, M.S.; Figueiro, M.G.; Bierman, A.; Bullough, J.D. Circadian light. J. Circadian Rhythms 2010, 8, 2. [CrossRef] 26. Ahearn, E.P. The use of visual analog scales in mood disorders: A critical review. J. Psychiatr. Res. 1997, 31, 569–579. [CrossRef] 27. Degner, L.F.; Sloan, J.A.; Venkatesh, P. The Control Preferences Scale. Can. J. Nurs. Res. 1997, 29, 21–43. 28. Arroll, B.; Elley, C.R.; Fishman, T.; Goodyear-Smith, F.A.; Kenealy, T.; Blashki, G.; Kerse, N.; MacGillivray, S. Antidepressants versus placebo for depression in primary care. Cochrane Database Syst. Rev. 2009. [CrossRef] 29. Ostuzzi, G.; Matcham, F.; Dauchy, S.; Barbui, C.; Hotopf, M. Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst. Rev. 2018. [CrossRef] 30. Lucas, R.J.; Peirson, S.N.; Berson, D.M.; Brown, T.M.; Cooper, H.M.; Czeisler, C.A.; Figueiro, M.G.; Gamlin, P.D.; Lockley, S.W.; O’Hagan, J.B.; et al. Measuring and using light in the melanopsin age. Trends Neurosci. 2014, 37, 1–9. [CrossRef] 31. Kronish, I.M.; Hampsey, M.; Falzon, L.; Konrad, B.; Davidson, K.W. Personalized (N-of-1) Trials for depression: A systematic review. J. Clin. Psychopharmacol. 2018, 38, 218–225. [CrossRef]PDF Image | Bright White Light Therapy for Depression in Cancer Survivors
PDF Search Title:
Bright White Light Therapy for Depression in Cancer SurvivorsOriginal File Name Searched:
healthcare-08-00010.pdfDIY PDF Search: Google It | Yahoo | Bing
Cruise Ship Reviews | Luxury Resort | Jet | Yacht | and Travel Tech More Info
Cruising Review Topics and Articles More Info
Software based on Filemaker for the travel industry More Info
The Burgenstock Resort: Reviews on CruisingReview website... More Info
Resort Reviews: World Class resorts... More Info
The Riffelalp Resort: Reviews on CruisingReview website... More Info
CONTACT TEL: 608-238-6001 Email: greg@cruisingreview.com (Standard Web Page)